Resultados de procura - David Tougeron
- Mostrando 1 - 20 Resultados de 59
- Go to Next Page
-
1
-
2
ABCB4/MDR3 gene mutations and cholangiocarcinomas por David Tougeron, Ginette Fotsing, Véronique Barbu, Michel Beauchant
Publicado 2012Carta -
3
-
4
Aspirin and Colorectal Cancer: Back to the Future por David Tougeron, Dan Sha, Sashidhar Manthravadi, Frank A. Sinicrope
Publicado 2013Revisão -
5
-
6
-
7
-
8
-
9
-
10
Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial por S. Ganame, T. Walter, A. Durand, Astrid Lièvre, David Tougeron, Jean–Yves Scoazec, E. Baudin, C. Lepage, Olayidé Boussari, Julien Hadoux
Publicado 2025Artigo -
11
Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐b... por Aziz Zaanan, Mélanie Gauthier, David Malka, Christophe Locher, Jean‐Marc Gornet, Anne Thirot‐Bidault, David Tougeron, Julien Taı̈eb, Franck Bonnetain, Thomas Aparicio
Publicado 2010Artigo -
12
Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer por David Tougeron, Thierry Lecomte, Jean‐Christophe Pagès, Claire Villalva, Christine Collin, Aurélie Ferru, J.M. Tourani, Christine Silvain, P. Levillain, L. Karayan-Tapon
Publicado 2013Artigo -
13
Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas por Frank A. Sinicrope, Thomas C. Smyrk, David Tougeron, Stephen N. Thibodeau, Shalini Singh, Andrea Murányi, Kandavel Shanmugam, Thomas M. Grogan, Steven R. Alberts, Qian Shi
Publicado 2013Artigo -
14
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor por Louis de Mestier, Thomas Walter, Camille Evrard, Paul de Boissieu, Olivia Hentic, Jérôme Cros, David Tougeron, Catherine Lombard‐Bohas, Vinciane Rebours, Pascal Hammel, Philippe Ruszniewski
Publicado 2019Artigo -
15
COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study por Violaine Randrian, Amale Dhimene, Armelle Pillet, Camille Evrard, Rayan Elfadel, Claire Boyer, Astrid Guyot d’Asnières de Salins, Isabelle Ingrand, Aurélie Ferru, Laetitia Rouleau, David Tougeron
Publicado 2025Artigo -
16
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study por Maëva Salimon, Caroline Prieux‐Klotz, David Tougeron, Vincent Hautefeuille, Morgane Caulet, Jérôme Gournay, Tamara Matysiak‐Budnik, Jaafar Bennouna, Manuela Tiako Meyo, Thierry Lecomte, Aziz Zaanan, Yann Touchefeu
Publicado 2017Artigo -
17
“Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial” por Julien Taı̈eb, Léonor Benhaïm, Pierre Laurent–Puig, Karine Le Malicot, Jean‐François Emile, Flore Geillon, David Tougeron, Sylvain Manfrédi, Marion Chauvenet, Valérie Taly, Côme Lepage, Thierry André
Publicado 2020Artigo -
18
Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer por Isabelle Iwanicki–Caron, Frédéric Di Fiore, Isabelle Roque, Emilie Astruc, Monica Stetiu, A. Duclos, David Tougeron, Sandrine Saillard, S. Thureau, Jacques Bénichou, B Paillot, J P Basuyau, Pierre Michel
Publicado 2008Artigo -
19
<i>KRAS</i> Codon 12 and 13 Mutations in Relation to Disease-Free Survival in <i>BRAF</i>–Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance) por Harry H. Yoon, David Tougeron, Qian Shi, Steven R. Alberts, Michelle R. Mahoney, Garth D. Nelson, Suresh Nair, Stephen N. Thibodeau, Richard M. Goldberg, Daniel J. Sargent, Frank A. Sinicrope
Publicado 2014Artigo -
20
Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu... por Antoine Adenis, Christelle de la Fouchardière, Bernard Paule, Pascal Burtin, David Tougeron, Jennifer Wallet, Louis-Marie Dourthe, Pierre-Luc Etienne, Laurent Mineur, Stéphanie Clisant, Jean-Marc Phélip, Andrew Kramar, Thierry André
Publicado 2016Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Cancer
Oncology
Colorectal cancer
Chemotherapy
Biology
Gastroenterology
Gene
Cancer research
Surgery
Allele
Microsatellite
Microsatellite instability
Immunotherapy
Clinical endpoint
Genetics
Biochemistry
Gemcitabine
Irinotecan
Phases of clinical research
Randomized controlled trial
Chemistry
Clinical trial
Oxaliplatin
Adverse effect
Cohort
Confidence interval
Environmental health
Nivolumab